This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - ALX Oncology Holdings (NASDAQ:

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Jefferies analyst Michael Yee upgraded ALX Oncology Holdings Inc. (NASDAQ:ALXO) from Hold to Buy and raised the price target from $2 to $3. ALX Oncology shares closed at $1.04 on Wednesday. See how other analysts view this stock.
Seaport Global analyst Kenneth Zener upgraded D.R. Horton, Inc. (NYSE:DHI) from Neutral to Buy and announced a $164 price target. D.R. Horton shares closed at $129.37 on Wednesday. See how other analysts view this stock.
Rosenblatt analyst Catharine Trebnick upgraded the rating for Zscaler, Inc. (NASDAQ:ZS) from Neutral to Buy and raised the price target from $190 to $235. Zscaler shares closed at $196.45 on Wednesday. See how other analysts view this stock.
Deutsche Bank analyst Abhi Agarwal upgraded Freeport-McMoRan Inc. (NYSE:FCX) from Hold to Buy and maintained the price target of $47. Freeport-McMoRan shares closed at $38.16 on Wednesday. See how other analysts view this stock.
Keybanc analyst Todd Thomas upgraded CubeSmart (NYSE:CUBE) from Sector Weight to Overweight and announced a $47 price target. CubeSmart shares closed at $42.46 on Wednesday. See how other analysts view this stock.